Literature DB >> 32307298

Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.

Farid Radmanesh1, Alicia Rodriguez-Pla2, Michael D Pincus3, Joseph D Burns4.   

Abstract

The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19.
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015).
OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute necrotizing encephalopathy; Adult onset Still’s disease; Diffuse hemorrhagic encephalopathy; Disseminated intravascular coagulation; Hemophagocytic syndrome

Mesh:

Year:  2020        PMID: 32307298      PMCID: PMC7162634          DOI: 10.1016/j.jocn.2020.04.054

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


Case report

Patient 1

A 46-year-old woman was admitted with a 3-month history of dyspnea, dysphagia and a generalized, maculopapular, and pruritic rash. She was febrile, tachycardic, and tachypneic. Neurological examination was normal. Her neurological status progressively worsened, and within 48 h she was alert, but followed no commands, anarthric, had significant spasticity, hyperreflexia and myoclonus. CT head (Fig. 1 A) and cerebrospinal fluid (CSF) analysis were unremarkable.
Fig. 1

Axial CT images of the brain from Patient 1 (A–C) and susceptibility-weighted MR images of the brain from patient 2 (D–F). Panel A, (admission) is normal. Panel B (HD 3) shows prominent, bilaterally symmetric thalamic hypodensities. Panel C (HD 5) shows diffuse, severe cerebral edema. Panels D-F (HD 5) demonstrate innumerable microscopic and small hemorrhages involving nearly all brain regions, with a predilection for subcortical white matter and the middle cerebellar peduncles.

Axial CT images of the brain from Patient 1 (A–C) and susceptibility-weighted MR images of the brain from patient 2 (D–F). Panel A, (admission) is normal. Panel B (HD 3) shows prominent, bilaterally symmetric thalamic hypodensities. Panel C (HD 5) shows diffuse, severe cerebral edema. Panels D-F (HD 5) demonstrate innumerable microscopic and small hemorrhages involving nearly all brain regions, with a predilection for subcortical white matter and the middle cerebellar peduncles. On hospital day (HD) 3, she developed coma with conjugate depressed gaze, intact brainstem reflexes and flexor posturing to pain. She was intubated and developed distributive shock. CT head showed bilateral symmetric thalamic hypodensities (Fig. 1B), consistent with ANE. Labs were markedly abnormal with thrombocytopenia, elevated creatinine, transaminitis, triglycerides of 1440 mg/dL, LDH of 1270 IU/L and ferritin of 40,000 ng/mL. Still’s disease with HLH was diagnosed based on Fautrel, Yamaguchi, and Henter criteria [5]. Bone marrow biopsy was consistent with HLH. Etoposide and high-dose dexamethasone were initiated. On HD 5 she developed severe hypotension; bradycardia; fixed, dilated pupils; and absent lower brainstem reflexes and motor responses. CT head revealed diffuse, severe cerebral edema with central transtentorial and transforaminal herniation (Fig. 1C). Life support was discontinued. Posthumously, elevated soluble CD25 (5950 pg/mL, Ref <=1033) and phagocytic histiocytes on bone marrow biopsy (H-score 98%) confirmed HLH. Post-mortem brain examination revealed diffuse edema, normal vessels, and early softening and discoloration of the bilateral thalami with prominent eosinophilic and pyknotic neurons.

Patient 2

A 44-year old woman presented after a 5-day outside hospitalization for fever, right upper quadrant abdominal pain, and transaminitis that rapidly progressed to altered consciousness, hypoxia, acute respiratory distress syndrome (ARDS), distributive shock, anuric renal failure, and disseminated intravascular coagulation (DIC). She required intubation and received empiric antibiotics for presumed cholecystitis and septic shock and was transferred to our hospital. Neurologic examination on arrival revealed coma, intact brainstem reflexes, flaccid quadriplegia, and diffuse hyperreflexia. Innumerable punctate hemorrhages throughout the cerebral hemispheres were seen in the CT head and brain MRI (Fig. 1D–F). Labs revealed anemia, thrombocytopenia, elevated creatinine of 5.2 mg/dL, transaminitis, triglycerides of 559 mg/dL, CK of 555 IU/L, LDH of 697 IU/L and ferritin of 4,921 ng/mL. Blood cultures were negative. High-dose dexamethasone was started for suspected HLH. Etoposide was added after bone marrow biopsy was consistent with HLH. She slowly improved, was extubated on HD 19 and at 2 months was living at home with a modified Rankin score of 2.

Discussion

We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: ANE, and diffuse hemorrhagic disease due to DIC. Severe HLH with brain involvement in adults is rare. A retrospective study found that 10% of 289 adult patients with HLH had central nervous system (CNS) involvement [2]. CSF and neuroimaging findings are typically unspecific [2]. ANE is an uncommon but distinctive type of acute, severe brain injury. ANE in children but not in adults with HLH has been reported [3]. Therefore, we herein describe the first case of an adult patient with HLH presenting with fulminant ANE. DIC has been described in 50% of the patients in a series of critically ill HLH patients admitted to intensive care unit [4]. Brain hemorrhage in adult patients with HLH was found in only 1 out of 289 adult patients with HLH [2]. Our patient presented with DIC resulting in rapid progression to multiple intracerebral hemorrhages with coma. Early suspicion of the underlying diagnosis prompted us to start timely treatment, which resulted in functional neurological recovery of the patient. Clinical manifestations, labs and imaging findings of HLH with CNS involvement are non-specific [1]. Early diagnosis and treatment is important to prevent serious complications and demise. Such diagnosis should be considered in patients with sepsis-like illness in the absence of an identifiable infection and disproportionately severe neurological manifestations. The existence of the HLH-like cytokine storm syndrome in adult patients with COVID-19 infection [6] which has, in at least one published case led to ANE [7], elevates the importance of a raised index of suspicion for these forms of severe cerebral injury in patients with COVID-19 infection.
  7 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study.

Authors:  Guilan Cai; Yini Wang; Xiaojing Liu; Yanfei Han; Zhao Wang
Journal:  Ann Hematol       Date:  2017-06-07       Impact factor: 3.673

Review 3.  Adult haemophagocytic syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Armando López-Guillermo; Munther A Khamashta; Xavier Bosch
Journal:  Lancet       Date:  2013-11-27       Impact factor: 79.321

Review 4.  Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder.

Authors:  Xiujuan Wu; Wei Wu; Wei Pan; Limin Wu; Kangding Liu; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

5.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

6.  COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.

Authors:  Neo Poyiadji; Gassan Shahin; Daniel Noujaim; Michael Stone; Suresh Patel; Brent Griffith
Journal:  Radiology       Date:  2020-03-31       Impact factor: 11.105

7.  Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.

Authors:  Sandrine Valade; Elie Azoulay; Lionel Galicier; David Boutboul; Lara Zafrani; Alain Stepanian; Emmanuel Canet; Virginie Lemiale; Marion Venot; Agnès Veyradier; Eric Mariotte
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total
  11 in total

Review 1.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

Review 2.  What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?

Authors:  Lena Al-Harthi; Edward Campbell; Julie A Schneider; David A Bennett
Journal:  AIDS Res Hum Retroviruses       Date:  2020-08-10       Impact factor: 2.205

Review 3.  Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

Authors:  Alejandro Romero; Eva Ramos; Francisco López-Muñoz; Emilio Gil-Martín; Germaine Escames; Russel J Reiter
Journal:  Cell Mol Neurobiol       Date:  2020-08-09       Impact factor: 4.231

Review 4.  Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.

Authors:  Parisorn Thepmankorn; John Bach; Ahmed Lasfar; Xilin Zhao; Sami Souayah; Zhao Zhong Chong; Nizar Souayah
Journal:  Cytokine       Date:  2020-12-11       Impact factor: 3.926

5.  An autopsy series of an oft-missed ante-mortem diagnosis: hemophagocytic lymphohistiocytosis.

Authors:  Anusree Majumder; Debraj Sen
Journal:  Autops Case Rep       Date:  2021-04-15

6.  Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.

Authors:  Umberto Pensato; Lorenzo Muccioli; Ilaria Cani; Damir Janigro; Pier Luigi Zinzani; Maria Guarino; Pietro Cortelli; Francesca Bisulli
Journal:  Ann Clin Transl Neurol       Date:  2021-03-29       Impact factor: 4.511

7.  Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect?

Authors:  David A Forero-Peña; Matthew M Hernandez; Iriana Paola Mozo Herrera; Iván Bolívar Collado Espinal; Joselyn Páez Paz; Carlos Ferro; David M Flora-Noda; Andrea L Maricuto; Viledy L Velásquez; Natasha A Camejo-Avila; Emilia M Sordillo; Lourdes A Delgado-Noguera; Luis A Perez-Garcia; Carlos G Morantes Rodríguez; María Eugenia Landaeta; Alberto E Paniz-Mondolfi
Journal:  J Med Virol       Date:  2021-11-19       Impact factor: 20.693

8.  Fatal Pediatric COVID-19 Case With Seizures and Fulminant Cerebral Edema.

Authors:  Siddharth Ninan; Peyton Thompson; Timothy Gershon; Natalie Ford; William Mills; Valerie Jewells; Leigh Thorne; Katherine Saunders; Thomas Bouldin; Jason R Smedberg; Melissa B Miller; Eveline Wu; Alyssa Tilly; Jeremy Sites; Daniel Lercher; Katherine Clement; Tracie Walker; Paul Shea; Benny Joyner; Rebecca Smith
Journal:  Child Neurol Open       Date:  2021-06-14

9.  Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.

Authors:  Jonathan Feld; Douglas Tremblay; Santiago Thibaud; Alaina Kessler; Leonard Naymagon
Journal:  Int J Lab Hematol       Date:  2020-08-13       Impact factor: 2.877

Review 10.  A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.

Authors:  Thomas Lung; Michel D Kazatchkine; Lorenz Risch; Martin Risch; Urs E Nydegger
Journal:  Transfus Apher Sci       Date:  2020-09-05       Impact factor: 1.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.